Government Drug Manufacturing Office to Lower Prices and Combat Shortages.
This Act establishes the Office of Drug Manufacturing within the HHS to tackle high prescription drug costs and market shortages, focusing initially on essential medicines like insulin, inhalers, and antibiotics. The Office will manufacture drugs, set a "fair price" for them, and sell them, aiming to increase patient access and reduce financial burdens on consumers and public health programs.
Key points
Establishes a federal Office of Drug Manufacturing to increase competition and lower prices for essential prescription drugs, including insulin and naloxone.
The Office is mandated to set a "fair price" for manufactured drugs, ensuring affordability and better patient access.
Within one year, the Office must begin manufacturing at least 15 applicable drugs, prioritizing those that significantly lower patient costs or address shortages.
Strict employment rules prohibit former drug industry lobbyists and senior executives of companies involved in certain legal misconduct from working in the Office.
Expired
Citizen Poll